Experienced in Transient Ischemic Attack (TIA)

Alvaro A. Avezum

Sao Paulo, SP, BR 
Experienced in Transient Ischemic Attack (TIA)
Sao Paulo, SP, BR 
OverviewLocationsClinical Research

Overview

Alvaro Avezum practices in Sao Paulo, Brazil. Mr. Avezum is rated as an Experienced expert by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Stroke, Severe Acute Respiratory Syndrome (SARS), COVID-19, Thrombectomy, and Leg or Foot Amputation.

His clinical research consists of co-authoring 257 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Transient Ischemic Attack (TIA).

Gender
Male

Locations

Sao Paulo, SP, Brazil
Other Locations
Alemao, RN, Brazil
1815-Bela Vista, Echapora, SP, Brazil
Santo Amaro, SP, Brazil
Florianopolis, SC, Brazil
Av. Dr. Dante Pazzanese, 500 Vila Mariana, Vila Mariana, SP 04012909, Brazil
Brazil
Paulo, MA, Brazil
Santos, SP, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomized, Pragmatic, Open Controlled Multicentre Study, Evaluating the Use of Rivaroxaban in Mild or Moderate COVID-19 Patients
Randomized, Pragmatic, Open Controlled Multicentre Study, Evaluating the Use of Rivaroxaban in Mild or Moderate COVID-19 Patients
Enrollment Status: Terminated
Publish Date: January 25, 2023
Intervention Type: Drug
Study Drug: Rivaroxaban
Study Phase: Phase 4
Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19
Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19
Enrollment Status: Completed
Publish Date: March 07, 2022
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 4
Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients
Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients
Enrollment Status: Completed
Publish Date: January 20, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

256 Total Publications

Stroke Outcomes in a Population-Focused Urban Hypertension Program in Brazil and Senegal.
Stroke Outcomes in a Population-Focused Urban Hypertension Program in Brazil and Senegal.
Journal: Journal of the American Heart Association
Published: April 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Avezum's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 32 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile